These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22652251)

  • 1. Treatment outcome of multidrug-resistant Mycobacterium tuberculosis in Nepal.
    Kakchapati S; Gyawali BN; Jha RK; Choonpradub C
    Asia Pac J Public Health; 2012 Jul; 24(4):631-40. PubMed ID: 22652251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of multidrug-resistant tuberculosis in Switzerland.
    Helbling P; Altpeter E; Egger JM; Zellweger JP
    Swiss Med Wkly; 2014; 144():w14053. PubMed ID: 25474040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Abebe M; Atnafu A; Tilahun M; Sero N; Neway S; Alemu M; Tesfaye G; Mihret A; Bobosha K; Wan C
    PLoS One; 2024; 19(5):e0304507. PubMed ID: 38820260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    Alene KA; Viney K; Yi H; McBryde ES; Yang K; Bai L; Gray DJ; Xu Z; Clements ACA
    PLoS One; 2018; 13(5):e0197880. PubMed ID: 29791488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
    Bang D; Lillebaek T; Thomsen VØ; Andersen AB
    Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P; Tabarsi P; Dorriz D; Marjani M; Shamaei M; Pooramiri MV; Mansouri D; Farnia P; Masjedi M; Velayati A
    Am J Ther; 2011; 18(2):e29-34. PubMed ID: 20019591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
    Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.